Harmony Biosciences Holdings Inc

HRMY · NASDAQ

Pharmaceutical Preparation Manufacturing

Harmony Biosciences Holdings, Inc. operates as a pharmaceutical company. The Company focuses on the research, drug development, and treatment for neurologic disorder of sleep-wake state instability. Harmony Biosciences Holdings serves patients in the United States.

ESG Scores

Overall ESG

4.5

Environmental

2.4

Social

3.3

Governance

5.4

Gender Diversity

Female Directors0.125%

Female Executives0.12371134020618557%

CEO GenderMale

Market Data

Price$32.96+0.86 (+2.68%)

Market Cap$1.86B

P/E Ratio12.76

EPS$—

52W High$40.87

52W Low$25.52

Beta0.98